News | May 19, 2026
Dyno unveils next-gen AI-designed gene delivery capsids targeting brain & muscle
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
The system is powered by BrainSense technology, which has received approval from USFDA
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
Subscribe To Our Newsletter & Stay Updated
